| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-119 |
Sentence |
denotes |
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. |
| TextSentencer_T2 |
120-130 |
Sentence |
denotes |
OBJECTIVE: |
| TextSentencer_T3 |
131-279 |
Sentence |
denotes |
Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern. |
| TextSentencer_T4 |
280-562 |
Sentence |
denotes |
This study aimed at investigating the global prevalence, biological and clinical characteristics of novel coronavirus, Wuhan China (2019-nCoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection outbreaks. |
| TextSentencer_T5 |
563-585 |
Sentence |
denotes |
MATERIALS AND METHODS: |
| TextSentencer_T6 |
586-804 |
Sentence |
denotes |
The data on the global outbreak of "2019-nCoV, SARS-CoV, and MERS-CoV" were obtained from World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), concerned ministries and research institutes. |
| TextSentencer_T7 |
805-1049 |
Sentence |
denotes |
We also recorded the information from research documents published in global scientific journals indexed in ISI Web of Science and research centers on the prevalence, biological and clinical characteristics of 2019-nCoV, SARS-CoV, and MERS-CoV. |
| TextSentencer_T8 |
1050-1058 |
Sentence |
denotes |
RESULTS: |
| TextSentencer_T9 |
1059-1190 |
Sentence |
denotes |
Worldwide, SARS-CoV involved 32 countries, with 8422 confirmed cases and 916 (10.87%) casualties from November 2002 to August 2003. |
| TextSentencer_T10 |
1191-1316 |
Sentence |
denotes |
MERS-CoV spread over 27 states, causing 2496 cases and 868 (34.77%) fatalities during the period April 2012 to December 2019. |
| TextSentencer_T11 |
1317-1408 |
Sentence |
denotes |
However, the novel coronavirus 2019-nCoV spread swiftly the global borders of 27 countries. |
| TextSentencer_T12 |
1409-1529 |
Sentence |
denotes |
It infected 34799 people and resulted in 724 (2.08%) casualties during the period December 29, 2019 to February 7, 2020. |
| TextSentencer_T13 |
1530-1720 |
Sentence |
denotes |
The fatality rate of coronavirus MERS-CoV was (34.77%) higher than SARS-CoV (10.87%) and 2019-nCoV (2.08%); however, the 2019-nCoV transmitted rapidly in comparison to SARS-CoV and MERS-CoV. |
| TextSentencer_T14 |
1721-1733 |
Sentence |
denotes |
CONCLUSIONS: |
| TextSentencer_T15 |
1734-1879 |
Sentence |
denotes |
The novel coronavirus 2019-nCoV has diverse epidemiological and biological characteristics, making it more contagious than SARS-CoV and MERS-CoV. |
| TextSentencer_T16 |
1880-2044 |
Sentence |
denotes |
It has affected more people in a short time period compared to SARS-CoV and MERS-CoV, although the fatality rate of MERS-CoV was higher than SARS-CoV and 2019-nCoV. |
| TextSentencer_T17 |
2045-2268 |
Sentence |
denotes |
The major clinical manifestations in coronavirus infections 2019-nCoV, MERS-CoV, and SARS CoV are fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, dyspnea, and pneumonia. |
| TextSentencer_T18 |
2269-2462 |
Sentence |
denotes |
Global health authorities should take immediate measures to prevent the outbreaks of such emerging and reemerging pathogens across the globe to minimize the disease burden locally and globally. |
